CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Young Teresa L. sold 3,338 shares at $0.81 ($2,704)
- 4 Planned sale Henn Matthew R. sold 3,953 shares at $0.81 ($3,204)
- 4 Planned sale CEO and President sold 12,726 shares at $0.81 ($10,314)
- 4 Planned sale Chief Legal Officer and EVP sold 4,300 shares at $0.81 ($3,485)
- 4 Planned sale von Moltke Lisa sold 4,416 shares at $0.81 ($3,579)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer and EVP sold 878 shares at $0.54 ($475)
- 4 Planned sale von Moltke Lisa sold 977 shares at $0.54 ($528)
- 4 Planned sale Young Teresa L. sold 735 shares at $0.54 ($398)
- 4 Planned sale CEO and President sold 2,505 shares at $0.54 ($1,355)
Page 4 of 19 · 380 filings